Small antibody fusion proteins with complementaritydetermining regions and lidamycin for tumor targeting therapy

Author：

ISSN： 1792-1074

Source： Oncology Letters, Vol.5, Iss.4, 2013-01, pp. : 1183-1188

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tumor-Targeting Peptides: Ligands for Molecular Imaging and Therapy

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 18, Iss. 1, 2018-03 ,pp. : 74-86

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Inhibitor of Apoptosis Proteins (IAPs) for Cancer Therapy

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 8, Iss. 5, 2008-06 ,pp. : 533-539

Bentham Science Publishers

Access to resources Recommend Favorite

Antitumor effect and mechanism of action of a tumor-targeting recombinant human tumor necrosis factor-α fusion protein mediated by urokinase

Molecular Medicine Reports, Vol. 11, Iss. 6, 2015-01 ,pp. : 4333-4340

Spandidos Publications

Access to resources Recommend Favorite

Matrix metalloproteinasemediation of tumor targeting human recombinant tumor necrosis factorα fusion protein

Molecular Medicine Reports, Vol. 12, Iss. 2, 2015-01 ,pp. : 2035-2042

Spandidos Publications

Access to resources Recommend Favorite

Review of Selected Patents for Cancer Therapy Targeting Tumor Angiogenesis

Recent Patents on Anti-Cancer Drug Discovery, Vol. 1, Iss. 2, 2006-06 ,pp. : 153-161

Bentham Science Publishers

Access to resources Recommend Favorite